Rituximab for IgG4-related disease: a prospective, open-label trial

Mollie N Carruthers; Mark D Topazian; Arezou Khosroshahi; Thomas E Witzig; Zachary S Wallace; Philip A Hart; Vikram Deshpande; Thomas C Smyrk; Suresh Chari; John H Stone

doi:10.1136/annrheumdis-2014-206605

Article info

Clinical and epidemiological research

Extended report

Rituximab for IgG4-related disease: a prospective, open-label trial

Authors

Mollie N Carruthers Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Mark D Topazian Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Arezou Khosroshahi Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA PubMed articles Google scholar articles
Thomas E Witzig Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articles Google scholar articles
Zachary S Wallace Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Philip A Hart Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Vikram Deshpande Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Thomas C Smyrk Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Suresh Chari Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
John H Stone Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles

Correspondence to Dr John H Stone, Rheumatology Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; jhstone{at}partners.org

View Full Text

Citation

Carruthers MN, Topazian MD, Khosroshahi A, et al

Rituximab for IgG4-related disease: a prospective, open-label trial

Annals of the Rheumatic Diseases 2015;74:1171-1177.

Publication history

Received September 10, 2014
Revised December 26, 2014
Accepted January 6, 2015
First published February 9, 2015.

Online issue publication

October 31, 2019

Article Versions

Previous version (8 February 2017).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password